EE191 A Budget Impact Analysis of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres Versus Atezolizumab-Bevacizumab as First-Line Therapy in Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma in England
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.441
https://www.valueinhealthjournal.com/article/S1098-3015(22)02645-6/fulltext
Section Title :
Section Order :
12248
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02645-6&doi=10.1016/j.jval.2022.09.441